​
​

Entero Therapeutics (FWBI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Entero Therapeutics Revenue Highlights

00

Entero Therapeutics Revenue by Period

Entero Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

Entero Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Entero Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$138.77K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31$2.06M100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31--

Entero Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Entero Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SGTXSigilon Therapeutics$12.94M$5.90M
SONNSonnet BioTherapeutics$147.81K-
XFORX4 Pharmaceuticals-$560.00K
PXMDPaxMedica--
ZURAZura Bio--
REVBRevelation Biosciences--
ICUSeaStar Medical--
HILSTharimmune--
FWBIEntero Therapeutics--
DRMADermata Therapeutics--
CFRXContraFect--
PHIOPhio Pharmaceuticals--
ZVSAZyVersa Therapeutics--
IMMXImmix Biopharma--
VIRIVirios Therapeutics--
EFTReFFECTOR Therapeutics--
QNRXQuoin Pharmaceuticals--
CDIOCardio Diagnostics-$6.58K
BWVOnconetix--

FWBI Revenue FAQ

What is Entero Therapeutics’s yearly revenue?

Entero Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. FWBI's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Entero Therapeutics’s quarterly revenue?

Entero Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $138.77K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). FWBI's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is Entero Therapeutics’s revenue growth rate?

Entero Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.